Rockwell Medical, Inc.
RMTI
$0.69
$0.033.81%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -5.51% | 15.19% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -5.51% | 15.19% | |||
| Cost of Revenue | -0.20% | 5.95% | |||
| Gross Profit | -25.30% | 70.69% | |||
| SG&A Expenses | 2.36% | 10.89% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.38% | 7.04% | |||
| Operating Income | -271.86% | 74.87% | |||
| Income Before Tax | -189.71% | 68.40% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -189.71% | 68.40% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -189.71% | 68.40% | |||
| EBIT | -271.86% | 74.87% | |||
| EBITDA | -754.73% | 114.23% | |||
| EPS Basic | -188.65% | 71.05% | |||
| Normalized Basic EPS | -168.63% | 67.62% | |||
| EPS Diluted | -171.33% | 70.00% | |||
| Normalized Diluted EPS | -168.63% | 67.62% | |||
| Average Basic Shares Outstanding | 0.03% | 9.38% | |||
| Average Diluted Shares Outstanding | 0.03% | 9.38% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||